HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Larger trials needed to confirm benefit of targeted therapies, immunotherapy for brain metastases
-
- Does WBRT still have a role for limited brain metastases?
- Don’t give up the day job John Sweetenham, MD, FRCP, FACP
- Providers must be prepared to accept new Medicare cards this spring Eugene Freund, MD, MSPH, CAPT USPHS
- BLU-285 induces rapid responses in advanced systemic mastocytosis
- Circulating tumor DNA reliably measures lymphoma disease burden
- Emicizumab-kxwh prophylaxis reduces bleeds among children with hemophilia A
- Pathologic complete response may be strong surrogate endpoint for breast cancer survival
- Researchers confirm axillary node dissection unnecessary for all node-positive breast cancers
-
- Venetoclax combination improves PFS in refractory chronic lymphotropic leukemia
- Oral chemotherapy parity laws modestly reduce out-of-pocket costs for patients
- Prognostic discussions may improve relationship between oncologists, patients with cancer
- Smoking, alcohol consumption predict poor head and neck cancer survival
- Genetic variant predicts clinical response to prostate cancer therapy
- Nivolumab shrinks HIV reservoir for French patient with lung cancer
- Stereotactic body radiotherapy promising for pancreatic cancer
- Men with esophageal cancer more likely to experience recurrence
-
- 2017 saw record number of FDA approvals for drugs
- FDA approves Hemlibra for hemophilia A
- FDA approves Ogivri, first biosimilar for certain breast, stomach cancers
- FDA approves Siklos for children with sickle cell anemia
- FDA grants priority review to rucaparib for certain gynecologic cancers
- Hoxworth Blood Center director appointed president of American Clinical and Climatological Association
- Medicaid expansion leads to earlier cancer detection
- Memorial Sloan Kettering Cancer Center names chair of neurosurgery
-
- Radiological Society of North America honors Mayo Clinic professor emeritus
- Sarah Cannon chief medical officer elected as next ASCO president